SQA
TTOO

Simon Quick Advisors’s T2 Biosystems, Inc TTOO Stock Holding History

Simon Quick Advisors’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1
Closed -$21K – 601
2017
Q3 		$21K Hold
1
– – 0.01% 362
2017
Q2 		$16K Buy
+1
New +$20K 0.01% 209

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Simon Quick Advisors's TTOO Position: Q4 2017 in Review

Simon Quick Advisors sold out of T2 Biosystems, Inc (TTOO) in Q4 2017, closing a stake of 1 share — an estimated $21K sold.

Simon Quick Advisors first reported a position in TTOO in Q2 2017 and held it in 2 quarters. The position peaked at $21K in Q3 2017. 35 funds tracked by Wall St. Rank hold TTOO as of Q4 2017.

  • Simon Quick Advisors reported no remaining T2 Biosystems, Inc position as of Q4 2017 after selling out during the quarter.
  • Simon Quick Advisors sold 1 T2 Biosystems, Inc share in Q4 2017, an estimated $21K.
  • Simon Quick Advisors first reported a position in T2 Biosystems, Inc in Q2 2017 and held it in 2 quarters.
  • Simon Quick Advisors's T2 Biosystems, Inc position peaked at $21K in Q3 2017.
  • 35 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2017.

Based on Simon Quick Advisors's 13F filing for Q4 2017, filed 13 Feb 2018.